Pulsesight
  • About us
    • About us
    • Team
    • Investors
  • Technology
  • Pipeline
    • Pipeline
    • About AMD
    • PST-611
    • PST-809
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Contact

Month: August 2026

Judith Greciet on Targeting Iron Dysregulation: PulseSight’s Next-Generation Approach to Geographic Atrophy

Posted on August 7, 2026August 7, 2026 by edgover
Judith Greciet on Targeting Iron Dysregulation: PulseSight’s Next-Generation Approach to Geographic Atrophy
Posted in In the news

Recent Posts

  • Judith Greciet on Targeting Iron Dysregulation: PulseSight’s Next-Generation Approach to Geographic Atrophy
  • PulseSight Therapeutics Reports P-I (PST-611-CT1) Trial Data on PST-611 in Dry AMD/Geographic Atrophy
  • PulseSight Reports Phase 1 GA Data
  • Positive Results from PulseSight’s Phase I Clinical Trial of PST-611 in Dry AMD/Geographic Atrophy Presented at ARVO 2026
  • PulseSight completes Phase 1 dosing of gene therapy candidate PST-611 in dry AMD and geographic atrophy

Recent Comments

No comments to show.

Archives

  • August 2026
  • May 2026
  • April 2026
  • January 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • April 2024
  • March 2024
  • February 2024

Categories

  • In the news
  • Press release
CONTACT US
PRIVACY POLICY
DISCLAIMER

© 2026 PULSESIGHT THERAPEUTICS ALL RIGHTS RESERVED